Oximeter: Gasping for regulatory oxygen profiteering in oximeter and need for immediate regulation (Record no. 519676)

000 -LEADER
fixed length control field 01773nam a22001577a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220411b ||||| |||| 00| 0 eng d
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Bhadala, Tilkesh
245 ## - TITLE STATEMENT
Title Oximeter: Gasping for regulatory oxygen profiteering in oximeter and need for immediate regulation
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc IIPA Digest
300 ## - PHYSICAL DESCRIPTION
Extent 3(2), Apr-Jun, 2021: p.26-30
520 ## - SUMMARY, ETC.
Summary, etc This article presents an analysis of ‘systemic loops’ in regulatory mechanisms during public health emergency, i.e. COVID-19 second wave. This ‘once in a century crisis’ has highlighted regulatory lapses and oversight in the functioning of the National Pharmaceutical Pricing Authority (NPPA). Taking specific case for oximeter, this article analyses that how the manufacturers and retailers used regulatory lapses for profiteering, rendering orders useless, toothless and ineffective, issued by National Pharmaceutical Pricing Authority (NPPA). Moreover, this underlines the problems in MRP regime and over reliance of regulator to depend on MRP as a key tool to regulate the prices. The later section of the article deals with the Drug Price Control Order, 2013 and powers provided by it to the NPPA- to take necessary measures to carry out its functions; ensuring quality, availability and affordability of the drugs. It also provides for viable alternatives to determine the prices using integration of data. The last part of article talks about possible impact of these regulatory lapses on income levels of lower-middle income groups and vulnerable sections of the society aggravating socio-economic inequity. – Reproduced
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element COVID-19, National Pharmaceutical Pricing Authority, NPPA, Oximeter
9 (RLIN) 30858
773 ## - HOST ITEM ENTRY
Main entry heading IIPA Digest
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
Subject DIP PHARMACEUTICAL PRICING
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Item type Articles
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Permanent location Current location Date acquired Serial Enumeration / chronology Barcode Date last seen Koha item type
          Indian Institute of Public Administration Indian Institute of Public Administration 2022-04-11 3(2), Apr-Jun, 2021: p.26-30 AR126475 2022-04-11 Articles

Powered by Koha